An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy
Yonsei University
Yonsei University
Massachusetts General Hospital
Xijing Hospital
National Institutes of Health Clinical Center (CC)
Universidad Europea de Madrid
Brigham and Women's Hospital
University of Southern California
Sunnybrook Health Sciences Centre
Duke University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Indiana University
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Institut Curie
Thomas Jefferson University
University of Alabama at Birmingham
Institut Curie
Institut Curie
Institut Cancerologie de l'Ouest
European Institute of Oncology
Centre Paul Strauss
Centre Henri Becquerel
Institut Curie
Ohio State University Comprehensive Cancer Center
University Medical Center Groningen
Yale University
Harbin Medical University
Institut Curie
UNICANCER
First Affiliated Hospital of Zhejiang University
M.D. Anderson Cancer Center
Vastra Gotaland Region
Peking University Cancer Hospital & Institute
Emory University
Zhejiang Provincial People's Hospital
Scripps Health
Ohio State University Comprehensive Cancer Center
UNICANCER
Stanford University
Sunnybrook Health Sciences Centre
Centro Hospitalar Universitário de Santo António
Institut Claudius Regaud
University Hospital of Cologne
The University of Tennessee, Knoxville
European Institute of Oncology
Samsung Medical Center
Samsung Medical Center